A year after moving into Center City from Princeton, healthcare data company IntegriChain is under new ownership.
Silicon Valley private equity firm Accel-KKR bought out IntegriChain’s existing investors, many of which were local, and now own a majority of the company. Terms of the deal were not disclosed. Those East Coast investors were Mt. Laurel, N.J.-based NJTC Venture Fund, New York City-based Milestone Venture Partners, New York City-based Cross Atlantic Partners (not to be confused with the Radnor venture firm that sued Facebook and who has since shut down), and Princeton-based investor Jeff Steinberg’s Redwood Pharma Ventures, which led IntegriChain’s 2011 Series C.
This is Accel-KKR’s first Philadelphia deal, a spokeswoman said.
IntegriChain, which provides data services to pharma companies like Merck and Sanofi, moved into Center City, on the third floor of 8 Penn Center, to help its recruiting efforts. The company has grown from 55 employees to 75 since moving into Philly and plans to hire more — though the company declined to quantify its hiring goals. (They have three job openings listed right now.)
The company is building out additional office space to accommodate growth. It also still has a small, four-person office in Princeton. Here’s a look inside their 11,000-square-foot space during a poker event five days ago:
Wistar Institute will use 3D-printed lung models made by Allevi for coronavirus research
Accolade, a Philly-Seattle health IT company, announces terms for IPO
Study: The Philly region is on track to add thousands more cell and gene therapy jobs in the next 10 years
How this Dreamit VC thinks about successful startups during a pandemic
Sign-up for daily news updates from Technical.ly Philadelphia